FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree H&T Group Plc(c)        Name of the party to the offer with which exempt principal trader is connected: H&T Group Plc(d)        Date dealing undertaken: 22 May 2025(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CRANEWARE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

THIS ANNOUNCEMENT IS PUBLISHED PURSUANT TO SECTION 21(3) OF EXECUTIVE ORDER NO. 636 OF 15 MAY 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Announcement of the final result of Nykredit’s recommended voluntary public tender offer for Spar Nord Bank A/S 23 May 2025 Nykredit announces the final result of the recommended voluntary public tender offer for Spar Nord Bank A/S In accordance with section 4(1) of the Danish Takeover Order1, Nykredit Realkredit A/S (“Nykredit”) announced on 10 December 2024 that Nykredit intended to submit a voluntary public takeover offer (the “Offer”) to acquire all shares in Spar Nord Bank A/S (“Spar Nord Bank”), with the exception of Spar Nord Bank’s treasury...

Nykredit has announced the final result of the takeover offer NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR TO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE CONTRARY TO APPLICABLE LEGISLATION OR RULES OF SUCH JURISDICTION With reference to Spar Nord Bank A/S’ (Spar Nord) company announcement no. 13/2025 concerning the preliminary result of the all-cash voluntary takeover offer from Nykredit Realkredit A/S (Nykredit) for all shares (other than treasury shares held by Spar Nord) in Spar Nord (the Offer), Nykredit has today announced the final result of the Offer. Nykredit’s announcement is attached. Final resultThe offer period expired on 20 May 2025 at 23:59 (CEST), and the preliminary result was announced on 21 May 2025. Nykredit has announced the final result of the Offer and informed...

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the acquisition to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc.VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the acquisition to acquire 100% of the issued and outstanding shares of NoBrainer Imaging Centers, Inc. (“NIC”) (the “Transaction”) previously announced on May 13, 2025. The Transaction moves Algernon into the Alzheimer’s Disease (“AD”) diagnostic and treatment market,...

SportsRecruits Joins NCSA College Recruiting as IMG Academy Services Aimed at Helping Student-Athletes and Coaches Navigate the Evolving College Sports Recruiting Landscape BRADENTON, Fla., May 22, 2025 (GLOBE NEWSWIRE) — IMG Academy, the world’s leading sports education brand, today announced the acquisition of SportsRecruits, a college sports recruiting service with specialized products for families, club and high school teams, college coaches and event operators. The acquisition brings SportsRecruits alongside IMG Academy’s NCSA College Recruiting to create an even more robust college sports recruiting network to help student-athletes and their families navigate the ever-evolving college sports landscape. The terms of the deal were not disclosed. The acquisition marks a significant milestone for IMG Academy as it continues to...

LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025. According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI on January 6, 2025, POAI’s stock price rose by more than 50%. Renovaro alleges...

Upon the recommendation of the ad hoc Committee, the Supervisory Board of Tarkett reiterates a favourable reasoned opinion on the fairness of the public buy-out Offer followed by a squeeze-out. This favourable reasoned opinion follows the submission by Finexsi of an addendum to its fairness opinion confirming the fairness of the Offer. PARIS, FRANCE, 22 MAY 2025 – Following observations by certain minority shareholders of Tarkett concerning the public buy-out offer followed by a squeeze-out (OPR-RO) on Tarkett shares initiated by Tarkett Participation at a price of €17 per share1 (the “Offer”) and the submission by Finexsi, acting as independent expert2, of an addendum to its fairness opinion confirming the fairness of the Offer, the Supervisory Board of Tarkett, based on the recommendation of the ad hoc Committee, reiterated its...

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICESOR FOR DISSEMINATION IN THE U.S./ TORONTO, May 22, 2025 (GLOBE NEWSWIRE) — Urbana Corporation (“Urbana” or the “Corporation”) (TSX and CSE: URB, URB.A) congratulates CSNX Markets Inc. (“CSE”) on its entering into an agreement with the NSX Limited (“NSX”) to acquire the NSX, owner of the National Stock Exchange of Australia (“NSXA”) in an all-cash transaction (the “Transaction”). This acquisition will enable the CSE to expand its geographic footprint by partnering with an exchange that has a similar focus and culture. Like the CSE, the NSXA is primarily focused on early stage, entrepreneurial companies, with particular strength in the resource sector. The NSXA is positioned to disrupt a market currently dominated by an incumbent, legacy exchange, as the CSE was over 20 years...

LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ: POAI), seeking to enforce a binding merger agreement executed on January 1, 2025. According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI on January 6, 2025, POAI’s stock price rose by more than 50%. Renovaro alleges...